Transcription of Annex 9 Guidelines on packaging for …
{{id}} {{{paragraph}}}
119 World Health OrganizationWHO Technical Report Series, No. 902, 2002 Annex 9 Guidelines on packaging for pharmaceuticalproductsIntroductory of of and , relabelling and inserts for patients (patient information leaflets) of of materials and of or types of assurance aspects of and of of the in The international for dosage form requirements for containers in Europe, Japanand the Standards145 References145 Bibliography147 Appendix 1 Storage areas150 Appendix 2 Labels151 Appendix 3 Self-inspection and quality audits152 Appendix 4 International Standards on packaging154 Introductory noteThis review of the various elements of the packaging of a pharmaceu-tical product is aimed at ensuring that medicines arrive safely i
121 The complexity of packaging materials and the highly technological nature of medicinal products is such that manufacturers are con-fronted with signi ficant problems.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
PVDC – New Developments, New Opportunities, Pharmaceutical Blister Packaging, For the disposal of, For the Disposal of Pharmaceutical Waste, Packaging, Blister, Pharmaceutical, Blister packaging, Regulations for Flexible Pharmaceutical, Regulations for Flexible Pharmaceutical Packaging, Of packaging material on Pharmaceutical, Of packaging material on Pharmaceutical product, CRITICAL SELECTION OF PRIMARY PACKAGING, Of Reserve Samples in Pharmaceutical, FOR PLAIN AND PRINTED, FOR PLAIN AND PRINTED FLEXIBLE LAMINATION